Myriad Genetics

Myriad Genetics, established in 1991, is a leading American molecular diagnostic company based in Utah. The company focuses on discovering, developing, and commercializing predictive, preventive, and prognostic molecular diagnostic tests across a spectrum of major diseases. Generating $829.0M in revenue and employing between 1,000 and 5,000 individuals, Myriad Genetics operates within a dynamic and competitive sector, contending with key players like Exact Sciences, Foundation Medicine, and Natera in the precision medicine market.

The core of Myriad Genetics's mission is to equip patients and healthcare professionals with critical genetic insights. These insights are designed to facilitate more informed treatment decisions, enhance patient outcomes, and promote proactive health management. The company's product suite features advanced molecular diagnostic tests aimed at identifying disease risks and guiding therapeutic strategies, particularly in oncology, but also encompassing other significant health conditions. This commitment to personalized medicine underscores their role in advancing healthcare through genomic science.

Myriad Genetics is driven by a commitment to scientific excellence and the collective expertise of its workforce. Meet Myriad Genetics's team to discover the professionals dedicated to advancing diagnostic capabilities. The company's strategic objectives include strengthening its current test offerings and expanding its development pipeline, fostering organic growth and delivering sustained value in the precision diagnostics field. By leveraging technological advancements and a deep understanding of disease biology, Myriad Genetics aims to empower individuals with the knowledge needed for better health and well-being.